Goldman Sachs AM PE Unit Buys Controlling Stake in Norgine

Posted on 05/28/2022

The Private Equity business within Goldman Sachs Asset Management agreed to buy a controlling stake in Dutch pharmaceutical company Norgine Europe B.V. from its founding family at a reported €1.9 billion enterprise value. The Stein Family will continue to own a significant stake in Norgine. Norgine has a diversified, differentiated portfolio of approximately 40 products. Norgine’s offering comprises the iconic MOVICOL brand. Norgine has a direct presence in 16 European countries, as well as Australia and New Zealand and employs over 1,500 people.

Norgine was advised by Moelis & Company, Rothschild & Co, Latham & Watkins LLP, PwC, and Jamieson Corporate Finance. Goldman Sachs Asset Management was advised by Goldman Sachs International – Investment Banking Division, Jefferies International Limited, White & Case LLP, and Deloitte LLP.

The transaction is subject to regulatory approvals and is expected to complete in 2022, following receipt of such approvals.

Get News, People, and Transactions, Delivered to Your Inbox